nodes	percent_of_prediction	percent_of_DWPC	metapath
Daunorubicin—POR—malignant glioma	0.491	0.713	CbGaD
Daunorubicin—TOP2A—malignant glioma	0.197	0.287	CbGaD
Daunorubicin—CYP1A2—Carmustine—malignant glioma	0.0491	0.569	CbGbCtD
Daunorubicin—CYP3A4—Temozolomide—malignant glioma	0.0371	0.43	CbGbCtD
Daunorubicin—Myelodysplastic syndrome—Temozolomide—malignant glioma	0.00449	0.0517	CcSEcCtD
Daunorubicin—Meningitis—Carmustine—malignant glioma	0.00241	0.0277	CcSEcCtD
Daunorubicin—Opportunistic infection—Temozolomide—malignant glioma	0.00224	0.0258	CcSEcCtD
Daunorubicin—Valrubicin—TOP2A—malignant glioma	0.00199	0.322	CrCbGaD
Daunorubicin—Lung infiltration—Carmustine—malignant glioma	0.00199	0.0229	CcSEcCtD
Daunorubicin—Myelosuppression—Carmustine—malignant glioma	0.00199	0.0229	CcSEcCtD
Daunorubicin—Myelosuppression—Temozolomide—malignant glioma	0.00192	0.0221	CcSEcCtD
Daunorubicin—NR5A1—brainstem—malignant glioma	0.00189	0.0575	CbGeAlD
Daunorubicin—Skin hyperpigmentation—Carmustine—malignant glioma	0.00157	0.0181	CcSEcCtD
Daunorubicin—Febrile neutropenia—Carmustine—malignant glioma	0.00155	0.0179	CcSEcCtD
Daunorubicin—Haemorrhoids—Temozolomide—malignant glioma	0.00153	0.0177	CcSEcCtD
Daunorubicin—Febrile neutropenia—Temozolomide—malignant glioma	0.0015	0.0173	CcSEcCtD
Daunorubicin—TOP2B—embryo—malignant glioma	0.00131	0.0399	CbGeAlD
Daunorubicin—ABCC6—retina—malignant glioma	0.00128	0.0389	CbGeAlD
Daunorubicin—Influenza-like symptoms—Temozolomide—malignant glioma	0.00126	0.0145	CcSEcCtD
Daunorubicin—Doxorubicin—POR—malignant glioma	0.00124	0.201	CrCbGaD
Daunorubicin—YWHAG—retina—malignant glioma	0.0012	0.0366	CbGeAlD
Daunorubicin—TOP2B—brainstem—malignant glioma	0.0012	0.0366	CbGeAlD
Daunorubicin—Necrosis—Carmustine—malignant glioma	0.00119	0.0137	CcSEcCtD
Daunorubicin—TOP2B—retina—malignant glioma	0.00116	0.0353	CbGeAlD
Daunorubicin—Idarubicin—TOP2A—malignant glioma	0.00115	0.185	CrCbGaD
Daunorubicin—YWHAG—telencephalon—malignant glioma	0.00111	0.0337	CbGeAlD
Daunorubicin—Rigors—Temozolomide—malignant glioma	0.0011	0.0127	CcSEcCtD
Daunorubicin—Extravasation—Carmustine—malignant glioma	0.00107	0.0123	CcSEcCtD
Daunorubicin—TOP2B—telencephalon—malignant glioma	0.00107	0.0325	CbGeAlD
Daunorubicin—Thinking abnormal—Carmustine—malignant glioma	0.00102	0.0117	CcSEcCtD
Daunorubicin—Viral infection—Temozolomide—malignant glioma	0.000998	0.0115	CcSEcCtD
Daunorubicin—Gait disturbance—Carmustine—malignant glioma	0.000956	0.011	CcSEcCtD
Daunorubicin—NR5A1—central nervous system—malignant glioma	0.000952	0.029	CbGeAlD
Daunorubicin—NR5A1—cerebellum—malignant glioma	0.00093	0.0283	CbGeAlD
Daunorubicin—Gait disturbance—Temozolomide—malignant glioma	0.000923	0.0106	CcSEcCtD
Daunorubicin—Neuropathy—Carmustine—malignant glioma	0.000876	0.0101	CcSEcCtD
Daunorubicin—Influenza like illness—Temozolomide—malignant glioma	0.000875	0.0101	CcSEcCtD
Daunorubicin—YWHAG—medulla oblongata—malignant glioma	0.000869	0.0265	CbGeAlD
Daunorubicin—Epirubicin—TOP2A—malignant glioma	0.000868	0.14	CrCbGaD
Daunorubicin—Neuropathy—Temozolomide—malignant glioma	0.000846	0.00974	CcSEcCtD
Daunorubicin—TOP2B—medulla oblongata—malignant glioma	0.000838	0.0255	CbGeAlD
Daunorubicin—Abnormal vision—Carmustine—malignant glioma	0.000813	0.00937	CcSEcCtD
Daunorubicin—Mental disability—Carmustine—malignant glioma	0.000809	0.00932	CcSEcCtD
Daunorubicin—YWHAG—midbrain—malignant glioma	0.000795	0.0242	CbGeAlD
Daunorubicin—Abnormal vision—Temozolomide—malignant glioma	0.000786	0.00905	CcSEcCtD
Daunorubicin—Mental disability—Temozolomide—malignant glioma	0.000782	0.00901	CcSEcCtD
Daunorubicin—Thrombophlebitis—Carmustine—malignant glioma	0.000782	0.00901	CcSEcCtD
Daunorubicin—YWHAG—spinal cord—malignant glioma	0.000775	0.0236	CbGeAlD
Daunorubicin—Ear pain—Temozolomide—malignant glioma	0.000767	0.00883	CcSEcCtD
Daunorubicin—TOP2B—midbrain—malignant glioma	0.000766	0.0233	CbGeAlD
Daunorubicin—Thrombophlebitis—Temozolomide—malignant glioma	0.000756	0.0087	CcSEcCtD
Daunorubicin—NR5A1—brain—malignant glioma	0.000756	0.023	CbGeAlD
Daunorubicin—Eye pain—Carmustine—malignant glioma	0.00075	0.00864	CcSEcCtD
Daunorubicin—TOP2B—spinal cord—malignant glioma	0.000747	0.0228	CbGeAlD
Daunorubicin—Deafness—Temozolomide—malignant glioma	0.000731	0.00842	CcSEcCtD
Daunorubicin—Eye pain—Temozolomide—malignant glioma	0.000725	0.00835	CcSEcCtD
Daunorubicin—Amnesia—Carmustine—malignant glioma	0.000721	0.0083	CcSEcCtD
Daunorubicin—Hot flush—Temozolomide—malignant glioma	0.000699	0.00805	CcSEcCtD
Daunorubicin—Amnesia—Temozolomide—malignant glioma	0.000696	0.00802	CcSEcCtD
Daunorubicin—Menopausal symptoms—Temozolomide—malignant glioma	0.000693	0.00798	CcSEcCtD
Daunorubicin—Thirst—Temozolomide—malignant glioma	0.000687	0.00792	CcSEcCtD
Daunorubicin—Gastrointestinal haemorrhage—Carmustine—malignant glioma	0.000677	0.0078	CcSEcCtD
Daunorubicin—ABCC10—telencephalon—malignant glioma	0.000667	0.0203	CbGeAlD
Daunorubicin—POR—medulla oblongata—malignant glioma	0.000661	0.0201	CbGeAlD
Daunorubicin—Affect lability—Temozolomide—malignant glioma	0.000644	0.00742	CcSEcCtD
Daunorubicin—Ataxia—Carmustine—malignant glioma	0.000637	0.00733	CcSEcCtD
Daunorubicin—YWHAG—central nervous system—malignant glioma	0.000629	0.0192	CbGeAlD
Daunorubicin—Mood swings—Temozolomide—malignant glioma	0.00062	0.00714	CcSEcCtD
Daunorubicin—Ataxia—Temozolomide—malignant glioma	0.000615	0.00708	CcSEcCtD
Daunorubicin—YWHAG—cerebellum—malignant glioma	0.000615	0.0187	CbGeAlD
Daunorubicin—Dehydration—Temozolomide—malignant glioma	0.000608	0.00701	CcSEcCtD
Daunorubicin—TOP2B—central nervous system—malignant glioma	0.000606	0.0185	CbGeAlD
Daunorubicin—POR—midbrain—malignant glioma	0.000604	0.0184	CbGeAlD
Daunorubicin—Dry skin—Temozolomide—malignant glioma	0.0006	0.00691	CcSEcCtD
Daunorubicin—TOP2B—cerebellum—malignant glioma	0.000592	0.018	CbGeAlD
Daunorubicin—POR—spinal cord—malignant glioma	0.000589	0.018	CbGeAlD
Daunorubicin—Dysphagia—Carmustine—malignant glioma	0.000585	0.00674	CcSEcCtD
Daunorubicin—Dysphagia—Temozolomide—malignant glioma	0.000565	0.00651	CcSEcCtD
Daunorubicin—Pancytopenia—Carmustine—malignant glioma	0.000556	0.0064	CcSEcCtD
Daunorubicin—Sweating increased—Temozolomide—malignant glioma	0.000551	0.00634	CcSEcCtD
Daunorubicin—Neutropenia—Carmustine—malignant glioma	0.000547	0.0063	CcSEcCtD
Daunorubicin—Pancytopenia—Temozolomide—malignant glioma	0.000537	0.00618	CcSEcCtD
Daunorubicin—Neutropenia—Temozolomide—malignant glioma	0.000529	0.00609	CcSEcCtD
Daunorubicin—Dysuria—Temozolomide—malignant glioma	0.000529	0.00609	CcSEcCtD
Daunorubicin—CYP1B1—telencephalon—malignant glioma	0.000525	0.016	CbGeAlD
Daunorubicin—ABCC10—medulla oblongata—malignant glioma	0.000524	0.016	CbGeAlD
Daunorubicin—Depression—Carmustine—malignant glioma	0.00052	0.00599	CcSEcCtD
Daunorubicin—Renal failure—Carmustine—malignant glioma	0.000513	0.00591	CcSEcCtD
Daunorubicin—Neuropathy peripheral—Carmustine—malignant glioma	0.000511	0.00589	CcSEcCtD
Daunorubicin—Stomatitis—Carmustine—malignant glioma	0.000509	0.00586	CcSEcCtD
Daunorubicin—Depression—Temozolomide—malignant glioma	0.000503	0.00579	CcSEcCtD
Daunorubicin—YWHAG—brain—malignant glioma	0.000499	0.0152	CbGeAlD
Daunorubicin—Doxorubicin—TOP2A—malignant glioma	0.000499	0.0805	CrCbGaD
Daunorubicin—Neuropathy peripheral—Temozolomide—malignant glioma	0.000494	0.00569	CcSEcCtD
Daunorubicin—Stomatitis—Temozolomide—malignant glioma	0.000491	0.00566	CcSEcCtD
Daunorubicin—TOP2B—brain—malignant glioma	0.000481	0.0147	CbGeAlD
Daunorubicin—ABCC10—midbrain—malignant glioma	0.000479	0.0146	CbGeAlD
Daunorubicin—Sinusitis—Temozolomide—malignant glioma	0.000473	0.00545	CcSEcCtD
Daunorubicin—ABCC1—telencephalon—malignant glioma	0.000472	0.0144	CbGeAlD
Daunorubicin—ABCC10—spinal cord—malignant glioma	0.000468	0.0142	CbGeAlD
Daunorubicin—POR—cerebellum—malignant glioma	0.000467	0.0142	CbGeAlD
Daunorubicin—Hallucination—Carmustine—malignant glioma	0.000466	0.00537	CcSEcCtD
Daunorubicin—Visual impairment—Carmustine—malignant glioma	0.000451	0.0052	CcSEcCtD
Daunorubicin—Hallucination—Temozolomide—malignant glioma	0.00045	0.00519	CcSEcCtD
Daunorubicin—Doxorubicin—CYP2B6—malignant glioma	0.000443	0.0716	CrCbGaD
Daunorubicin—Visual impairment—Temozolomide—malignant glioma	0.000436	0.00502	CcSEcCtD
Daunorubicin—Flushing—Carmustine—malignant glioma	0.000435	0.00501	CcSEcCtD
Daunorubicin—Tinnitus—Temozolomide—malignant glioma	0.000422	0.00486	CcSEcCtD
Daunorubicin—Cardiac disorder—Temozolomide—malignant glioma	0.00042	0.00484	CcSEcCtD
Daunorubicin—Flushing—Temozolomide—malignant glioma	0.00042	0.00484	CcSEcCtD
Daunorubicin—Arrhythmia—Carmustine—malignant glioma	0.000418	0.00482	CcSEcCtD
Daunorubicin—Alopecia—Carmustine—malignant glioma	0.000414	0.00477	CcSEcCtD
Daunorubicin—Erythema—Carmustine—malignant glioma	0.000408	0.00469	CcSEcCtD
Daunorubicin—Chills—Temozolomide—malignant glioma	0.000406	0.00468	CcSEcCtD
Daunorubicin—Alopecia—Temozolomide—malignant glioma	0.0004	0.00461	CcSEcCtD
Daunorubicin—ABCB1—blood vessel—malignant glioma	0.000397	0.0121	CbGeAlD
Daunorubicin—Back pain—Carmustine—malignant glioma	0.000394	0.00454	CcSEcCtD
Daunorubicin—Erythema—Temozolomide—malignant glioma	0.000394	0.00454	CcSEcCtD
Daunorubicin—ABCG2—telencephalon—malignant glioma	0.000391	0.0119	CbGeAlD
Daunorubicin—Dysgeusia—Temozolomide—malignant glioma	0.000386	0.00444	CcSEcCtD
Daunorubicin—Tremor—Carmustine—malignant glioma	0.000382	0.0044	CcSEcCtD
Daunorubicin—Back pain—Temozolomide—malignant glioma	0.000381	0.00439	CcSEcCtD
Daunorubicin—POR—brain—malignant glioma	0.00038	0.0116	CbGeAlD
Daunorubicin—Anaemia—Carmustine—malignant glioma	0.000377	0.00434	CcSEcCtD
Daunorubicin—Agitation—Carmustine—malignant glioma	0.000375	0.00431	CcSEcCtD
Daunorubicin—ABCC10—cerebellum—malignant glioma	0.000371	0.0113	CbGeAlD
Daunorubicin—Tremor—Temozolomide—malignant glioma	0.000369	0.00425	CcSEcCtD
Daunorubicin—Ill-defined disorder—Temozolomide—malignant glioma	0.000366	0.00421	CcSEcCtD
Daunorubicin—Leukopenia—Carmustine—malignant glioma	0.000365	0.0042	CcSEcCtD
Daunorubicin—Anaemia—Temozolomide—malignant glioma	0.000364	0.00419	CcSEcCtD
Daunorubicin—Agitation—Temozolomide—malignant glioma	0.000362	0.00417	CcSEcCtD
Daunorubicin—Malaise—Temozolomide—malignant glioma	0.000355	0.00409	CcSEcCtD
Daunorubicin—Convulsion—Carmustine—malignant glioma	0.000353	0.00407	CcSEcCtD
Daunorubicin—Leukopenia—Temozolomide—malignant glioma	0.000353	0.00406	CcSEcCtD
Daunorubicin—Hypertension—Carmustine—malignant glioma	0.000352	0.00405	CcSEcCtD
Daunorubicin—Palpitations—Temozolomide—malignant glioma	0.000348	0.00401	CcSEcCtD
Daunorubicin—Myalgia—Carmustine—malignant glioma	0.000347	0.004	CcSEcCtD
Daunorubicin—Chest pain—Carmustine—malignant glioma	0.000347	0.004	CcSEcCtD
Daunorubicin—Anxiety—Carmustine—malignant glioma	0.000346	0.00398	CcSEcCtD
Daunorubicin—Cough—Temozolomide—malignant glioma	0.000344	0.00396	CcSEcCtD
Daunorubicin—Convulsion—Temozolomide—malignant glioma	0.000341	0.00393	CcSEcCtD
Daunorubicin—Hypertension—Temozolomide—malignant glioma	0.00034	0.00392	CcSEcCtD
Daunorubicin—Confusional state—Carmustine—malignant glioma	0.000336	0.00386	CcSEcCtD
Daunorubicin—Arthralgia—Temozolomide—malignant glioma	0.000335	0.00386	CcSEcCtD
Daunorubicin—Myalgia—Temozolomide—malignant glioma	0.000335	0.00386	CcSEcCtD
Daunorubicin—Anxiety—Temozolomide—malignant glioma	0.000334	0.00385	CcSEcCtD
Daunorubicin—Oedema—Carmustine—malignant glioma	0.000333	0.00383	CcSEcCtD
Daunorubicin—Discomfort—Temozolomide—malignant glioma	0.000331	0.00382	CcSEcCtD
Daunorubicin—Infection—Carmustine—malignant glioma	0.000331	0.00381	CcSEcCtD
Daunorubicin—Dry mouth—Temozolomide—malignant glioma	0.000328	0.00378	CcSEcCtD
Daunorubicin—Thrombocytopenia—Carmustine—malignant glioma	0.000326	0.00375	CcSEcCtD
Daunorubicin—Tachycardia—Carmustine—malignant glioma	0.000325	0.00374	CcSEcCtD
Daunorubicin—Confusional state—Temozolomide—malignant glioma	0.000324	0.00373	CcSEcCtD
Daunorubicin—Oedema—Temozolomide—malignant glioma	0.000322	0.0037	CcSEcCtD
Daunorubicin—Anaphylactic shock—Temozolomide—malignant glioma	0.000322	0.0037	CcSEcCtD
Daunorubicin—Infection—Temozolomide—malignant glioma	0.000319	0.00368	CcSEcCtD
Daunorubicin—Anorexia—Carmustine—malignant glioma	0.000317	0.00365	CcSEcCtD
Daunorubicin—Thrombocytopenia—Temozolomide—malignant glioma	0.000315	0.00363	CcSEcCtD
Daunorubicin—Hyperhidrosis—Temozolomide—malignant glioma	0.000311	0.00358	CcSEcCtD
Daunorubicin—ABCG2—medulla oblongata—malignant glioma	0.000307	0.00936	CbGeAlD
Daunorubicin—Anorexia—Temozolomide—malignant glioma	0.000307	0.00353	CcSEcCtD
Daunorubicin—Musculoskeletal discomfort—Carmustine—malignant glioma	0.000303	0.00349	CcSEcCtD
Daunorubicin—ABCC10—brain—malignant glioma	0.000301	0.00918	CbGeAlD
Daunorubicin—Insomnia—Carmustine—malignant glioma	0.000301	0.00347	CcSEcCtD
Daunorubicin—CYP1B1—central nervous system—malignant glioma	0.000298	0.00909	CbGeAlD
Daunorubicin—Dyspnoea—Carmustine—malignant glioma	0.000297	0.00342	CcSEcCtD
Daunorubicin—Somnolence—Carmustine—malignant glioma	0.000296	0.00341	CcSEcCtD
Daunorubicin—Musculoskeletal discomfort—Temozolomide—malignant glioma	0.000293	0.00337	CcSEcCtD
Daunorubicin—CYP1B1—cerebellum—malignant glioma	0.000292	0.00888	CbGeAlD
Daunorubicin—Insomnia—Temozolomide—malignant glioma	0.000291	0.00335	CcSEcCtD
Daunorubicin—Decreased appetite—Carmustine—malignant glioma	0.000289	0.00333	CcSEcCtD
Daunorubicin—Dyspnoea—Temozolomide—malignant glioma	0.000287	0.0033	CcSEcCtD
Daunorubicin—Somnolence—Temozolomide—malignant glioma	0.000286	0.00329	CcSEcCtD
Daunorubicin—Pain—Carmustine—malignant glioma	0.000285	0.00328	CcSEcCtD
Daunorubicin—Constipation—Carmustine—malignant glioma	0.000285	0.00328	CcSEcCtD
Daunorubicin—ABCG2—midbrain—malignant glioma	0.000281	0.00855	CbGeAlD
Daunorubicin—Decreased appetite—Temozolomide—malignant glioma	0.00028	0.00322	CcSEcCtD
Daunorubicin—Fatigue—Temozolomide—malignant glioma	0.000277	0.00319	CcSEcCtD
Daunorubicin—Constipation—Temozolomide—malignant glioma	0.000275	0.00317	CcSEcCtD
Daunorubicin—Pain—Temozolomide—malignant glioma	0.000275	0.00317	CcSEcCtD
Daunorubicin—Feeling abnormal—Carmustine—malignant glioma	0.000274	0.00316	CcSEcCtD
Daunorubicin—ABCG2—spinal cord—malignant glioma	0.000274	0.00834	CbGeAlD
Daunorubicin—Gastrointestinal pain—Carmustine—malignant glioma	0.000272	0.00313	CcSEcCtD
Daunorubicin—Feeling abnormal—Temozolomide—malignant glioma	0.000265	0.00305	CcSEcCtD
Daunorubicin—Abdominal pain—Carmustine—malignant glioma	0.000263	0.00303	CcSEcCtD
Daunorubicin—Body temperature increased—Carmustine—malignant glioma	0.000263	0.00303	CcSEcCtD
Daunorubicin—Gastrointestinal pain—Temozolomide—malignant glioma	0.000263	0.00303	CcSEcCtD
Daunorubicin—ABCC1—cerebellum—malignant glioma	0.000262	0.00799	CbGeAlD
Daunorubicin—Urticaria—Temozolomide—malignant glioma	0.000255	0.00294	CcSEcCtD
Daunorubicin—Abdominal pain—Temozolomide—malignant glioma	0.000254	0.00293	CcSEcCtD
Daunorubicin—Body temperature increased—Temozolomide—malignant glioma	0.000254	0.00293	CcSEcCtD
Daunorubicin—Hypersensitivity—Carmustine—malignant glioma	0.000245	0.00282	CcSEcCtD
Daunorubicin—Asthenia—Carmustine—malignant glioma	0.000239	0.00275	CcSEcCtD
Daunorubicin—ABCB1—embryo—malignant glioma	0.000237	0.00722	CbGeAlD
Daunorubicin—Hypersensitivity—Temozolomide—malignant glioma	0.000237	0.00273	CcSEcCtD
Daunorubicin—CYP1B1—brain—malignant glioma	0.000237	0.00722	CbGeAlD
Daunorubicin—Asthenia—Temozolomide—malignant glioma	0.000231	0.00266	CcSEcCtD
Daunorubicin—Diarrhoea—Carmustine—malignant glioma	0.000228	0.00262	CcSEcCtD
Daunorubicin—Pruritus—Temozolomide—malignant glioma	0.000228	0.00262	CcSEcCtD
Daunorubicin—Dizziness—Carmustine—malignant glioma	0.00022	0.00253	CcSEcCtD
Daunorubicin—Diarrhoea—Temozolomide—malignant glioma	0.00022	0.00253	CcSEcCtD
Daunorubicin—ABCG2—cerebellum—malignant glioma	0.000217	0.00662	CbGeAlD
Daunorubicin—ABCC1—brain—malignant glioma	0.000213	0.00649	CbGeAlD
Daunorubicin—Dizziness—Temozolomide—malignant glioma	0.000213	0.00245	CcSEcCtD
Daunorubicin—Vomiting—Carmustine—malignant glioma	0.000212	0.00244	CcSEcCtD
Daunorubicin—CYP1A1—central nervous system—malignant glioma	0.000211	0.00643	CbGeAlD
Daunorubicin—Rash—Carmustine—malignant glioma	0.00021	0.00242	CcSEcCtD
Daunorubicin—Dermatitis—Carmustine—malignant glioma	0.00021	0.00241	CcSEcCtD
Daunorubicin—ABCB1—retina—malignant glioma	0.00021	0.00638	CbGeAlD
Daunorubicin—Headache—Carmustine—malignant glioma	0.000208	0.0024	CcSEcCtD
Daunorubicin—Vomiting—Temozolomide—malignant glioma	0.000204	0.00235	CcSEcCtD
Daunorubicin—Rash—Temozolomide—malignant glioma	0.000203	0.00233	CcSEcCtD
Daunorubicin—Dermatitis—Temozolomide—malignant glioma	0.000203	0.00233	CcSEcCtD
Daunorubicin—Headache—Temozolomide—malignant glioma	0.000201	0.00232	CcSEcCtD
Daunorubicin—Nausea—Carmustine—malignant glioma	0.000198	0.00228	CcSEcCtD
Daunorubicin—ABCB1—telencephalon—malignant glioma	0.000193	0.00587	CbGeAlD
Daunorubicin—Nausea—Temozolomide—malignant glioma	0.000191	0.0022	CcSEcCtD
Daunorubicin—ABCG2—brain—malignant glioma	0.000176	0.00537	CbGeAlD
Daunorubicin—CYP1A1—brain—malignant glioma	0.000167	0.0051	CbGeAlD
Daunorubicin—CYP3A4—central nervous system—malignant glioma	0.000155	0.00472	CbGeAlD
Daunorubicin—ABCB1—medulla oblongata—malignant glioma	0.000151	0.00461	CbGeAlD
Daunorubicin—ABCB1—midbrain—malignant glioma	0.000138	0.00422	CbGeAlD
Daunorubicin—ABCB1—spinal cord—malignant glioma	0.000135	0.00411	CbGeAlD
Daunorubicin—ABCB1—central nervous system—malignant glioma	0.00011	0.00334	CbGeAlD
Daunorubicin—ABCB1—cerebellum—malignant glioma	0.000107	0.00326	CbGeAlD
Daunorubicin—ABCB1—brain—malignant glioma	8.7e-05	0.00265	CbGeAlD
Daunorubicin—XDH—Metabolism—PPARG—malignant glioma	1.15e-05	0.000116	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—IDH1—malignant glioma	1.15e-05	0.000116	CbGpPWpGaD
Daunorubicin—SLC22A2—Metabolism—PTGS1—malignant glioma	1.14e-05	0.000115	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	1.14e-05	0.000115	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	1.13e-05	0.000114	CbGpPWpGaD
Daunorubicin—ABCC2—Transmembrane transport of small molecules—RAF1—malignant glioma	1.12e-05	0.000113	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—CDKN2B—malignant glioma	1.12e-05	0.000113	CbGpPWpGaD
Daunorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—malignant glioma	1.12e-05	0.000113	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism of lipids and lipoproteins—PTGS1—malignant glioma	1.12e-05	0.000113	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—SPHK1—malignant glioma	1.11e-05	0.000112	CbGpPWpGaD
Daunorubicin—ABCC1—Transmembrane transport of small molecules—RAF1—malignant glioma	1.11e-05	0.000112	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	1.1e-05	0.000111	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	1.09e-05	0.00011	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—CYP2C18—malignant glioma	1.09e-05	0.00011	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—IDH1—malignant glioma	1.09e-05	0.00011	CbGpPWpGaD
Daunorubicin—ABCG2—Metabolism—BCHE—malignant glioma	1.07e-05	0.000108	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—HES1—malignant glioma	1.07e-05	0.000108	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—NCOR1—malignant glioma	1.06e-05	0.000107	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—ASMT—malignant glioma	1.06e-05	0.000107	CbGpPWpGaD
Daunorubicin—SLC22A2—Metabolism—BCHE—malignant glioma	1.06e-05	0.000107	CbGpPWpGaD
Daunorubicin—ABCG2—Metabolism—SLC5A5—malignant glioma	1.06e-05	0.000107	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—SPHK1—malignant glioma	1.05e-05	0.000106	CbGpPWpGaD
Daunorubicin—XDH—Metabolism—PIK3CD—malignant glioma	1.05e-05	0.000106	CbGpPWpGaD
Daunorubicin—SLC22A2—Metabolism—SLC5A5—malignant glioma	1.05e-05	0.000106	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—malignant glioma	1.04e-05	0.000105	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—CYP2C18—malignant glioma	1.03e-05	0.000104	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—PDGFRA—malignant glioma	1.02e-05	0.000103	CbGpPWpGaD
Daunorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—malignant glioma	1.01e-05	0.000102	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—IDH2—malignant glioma	1.01e-05	0.000102	CbGpPWpGaD
Daunorubicin—TOP2A—Cell Cycle—TP53—malignant glioma	1.01e-05	0.000101	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—BCAN—malignant glioma	1e-05	0.000101	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	9.84e-06	9.91e-05	CbGpPWpGaD
Daunorubicin—ABCG2—Transmembrane transport of small molecules—RAF1—malignant glioma	9.76e-06	9.83e-05	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	9.72e-06	9.79e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism—GSTP1—malignant glioma	9.7e-06	9.77e-05	CbGpPWpGaD
Daunorubicin—ABCB11—Metabolism—CAV1—malignant glioma	9.68e-06	9.74e-05	CbGpPWpGaD
Daunorubicin—SLC22A2—Transmembrane transport of small molecules—RAF1—malignant glioma	9.66e-06	9.73e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—COX8A—malignant glioma	9.66e-06	9.73e-05	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	9.52e-06	9.59e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—CYP2B6—malignant glioma	9.5e-06	9.56e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism—CAT—malignant glioma	9.44e-06	9.51e-05	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism—GSTP1—malignant glioma	9.39e-06	9.45e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—TERT—malignant glioma	9.38e-06	9.45e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—HLA-A—malignant glioma	9.38e-06	9.45e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—malignant glioma	9.32e-06	9.38e-05	CbGpPWpGaD
Daunorubicin—ABCB11—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	9.25e-06	9.31e-05	CbGpPWpGaD
Daunorubicin—XDH—Metabolism—PIK3CB—malignant glioma	9.16e-06	9.22e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—PDGFB—malignant glioma	9.16e-06	9.22e-05	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism—CAT—malignant glioma	9.13e-06	9.2e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—malignant glioma	9.12e-06	9.18e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—FGFR1—malignant glioma	9.11e-06	9.17e-05	CbGpPWpGaD
Daunorubicin—XDH—Metabolism—PTGS2—malignant glioma	9.08e-06	9.14e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—HIF1A—malignant glioma	8.97e-06	9.04e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism—NCOR1—malignant glioma	8.92e-06	8.98e-05	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	8.86e-06	8.92e-05	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—GSTT1—malignant glioma	8.83e-06	8.89e-05	CbGpPWpGaD
Daunorubicin—ABCB11—Metabolism—PIK3CG—malignant glioma	8.81e-06	8.88e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—IDH1—malignant glioma	8.69e-06	8.75e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—malignant glioma	8.68e-06	8.74e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—CAV1—malignant glioma	8.68e-06	8.74e-05	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism—NCOR1—malignant glioma	8.63e-06	8.68e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—malignant glioma	8.61e-06	8.67e-05	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	8.55e-06	8.61e-05	CbGpPWpGaD
Daunorubicin—ABCG2—Metabolism—GSTP1—malignant glioma	8.54e-06	8.6e-05	CbGpPWpGaD
Daunorubicin—ABCB11—Metabolism—PPARG—malignant glioma	8.51e-06	8.57e-05	CbGpPWpGaD
Daunorubicin—SLC22A2—Metabolism—GSTP1—malignant glioma	8.45e-06	8.51e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—SPHK1—malignant glioma	8.41e-06	8.46e-05	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—GSTT1—malignant glioma	8.34e-06	8.4e-05	CbGpPWpGaD
Daunorubicin—ABCG2—Metabolism—CAT—malignant glioma	8.31e-06	8.37e-05	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—PTGS1—malignant glioma	8.27e-06	8.33e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—CYP2C18—malignant glioma	8.24e-06	8.29e-05	CbGpPWpGaD
Daunorubicin—SLC22A2—Metabolism—CAT—malignant glioma	8.22e-06	8.28e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—ASMT—malignant glioma	8.21e-06	8.27e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—BAD—malignant glioma	8.16e-06	8.22e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—NOTCH1—malignant glioma	8.09e-06	8.14e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—IDH2—malignant glioma	8.06e-06	8.12e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—CD80—malignant glioma	7.92e-06	7.98e-05	CbGpPWpGaD
Daunorubicin—XDH—Metabolism—PTEN—malignant glioma	7.92e-06	7.97e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—malignant glioma	7.91e-06	7.97e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—APC—malignant glioma	7.91e-06	7.96e-05	CbGpPWpGaD
Daunorubicin—ABCG2—Metabolism—NCOR1—malignant glioma	7.85e-06	7.9e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—EGF—malignant glioma	7.82e-06	7.87e-05	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—PTGS1—malignant glioma	7.81e-06	7.87e-05	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	7.79e-06	7.84e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—PTPN11—malignant glioma	7.77e-06	7.82e-05	CbGpPWpGaD
Daunorubicin—SLC22A2—Metabolism—NCOR1—malignant glioma	7.77e-06	7.82e-05	CbGpPWpGaD
Daunorubicin—ABCB11—Metabolism—PIK3CD—malignant glioma	7.75e-06	7.8e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—BCAN—malignant glioma	7.72e-06	7.77e-05	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—BCHE—malignant glioma	7.69e-06	7.74e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—malignant glioma	7.65e-06	7.71e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	7.6e-06	7.66e-05	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—SLC5A5—malignant glioma	7.6e-06	7.65e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—CYP2B6—malignant glioma	7.58e-06	7.63e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—BRAF—malignant glioma	7.43e-06	7.48e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism—CAV1—malignant glioma	7.27e-06	7.32e-05	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—BCHE—malignant glioma	7.26e-06	7.31e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—AKT2—malignant glioma	7.23e-06	7.28e-05	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—SLC5A5—malignant glioma	7.18e-06	7.22e-05	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism—CAV1—malignant glioma	7.03e-06	7.08e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—PIK3CD—malignant glioma	6.95e-06	7e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	6.95e-06	6.99e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—IDH1—malignant glioma	6.94e-06	6.98e-05	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	6.79e-06	6.83e-05	CbGpPWpGaD
Daunorubicin—ABCB11—Metabolism—PIK3CB—malignant glioma	6.75e-06	6.8e-05	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	6.72e-06	6.77e-05	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	6.72e-06	6.76e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—SPHK1—malignant glioma	6.71e-06	6.76e-05	CbGpPWpGaD
Daunorubicin—ABCB11—Metabolism—PTGS2—malignant glioma	6.69e-06	6.74e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—GSTT1—malignant glioma	6.66e-06	6.71e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—FGF2—malignant glioma	6.66e-06	6.7e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism—PIK3CG—malignant glioma	6.62e-06	6.67e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—CYP2C18—malignant glioma	6.57e-06	6.62e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—malignant glioma	6.46e-06	6.51e-05	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism—PIK3CG—malignant glioma	6.4e-06	6.45e-05	CbGpPWpGaD
Daunorubicin—ABCG2—Metabolism—CAV1—malignant glioma	6.4e-06	6.44e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism—PPARG—malignant glioma	6.39e-06	6.43e-05	CbGpPWpGaD
Daunorubicin—SLC22A2—Metabolism—CAV1—malignant glioma	6.33e-06	6.37e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—PTGS1—malignant glioma	6.24e-06	6.28e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—MDM2—malignant glioma	6.23e-06	6.27e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—IDH2—malignant glioma	6.22e-06	6.27e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—RAF1—malignant glioma	6.21e-06	6.25e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	6.2e-06	6.24e-05	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism—PPARG—malignant glioma	6.18e-06	6.22e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—ERBB2—malignant glioma	6.14e-06	6.18e-05	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—GSTP1—malignant glioma	6.12e-06	6.16e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—PIK3CB—malignant glioma	6.06e-06	6.1e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—PTGS2—malignant glioma	6e-06	6.04e-05	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—CAT—malignant glioma	5.95e-06	5.99e-05	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	5.86e-06	5.9e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—CYP2B6—malignant glioma	5.85e-06	5.89e-05	CbGpPWpGaD
Daunorubicin—ABCB11—Metabolism—PTEN—malignant glioma	5.84e-06	5.88e-05	CbGpPWpGaD
Daunorubicin—ABCG2—Metabolism—PIK3CG—malignant glioma	5.83e-06	5.87e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism—PIK3CD—malignant glioma	5.82e-06	5.86e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—BCHE—malignant glioma	5.8e-06	5.84e-05	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—GSTP1—malignant glioma	5.78e-06	5.82e-05	CbGpPWpGaD
Daunorubicin—SLC22A2—Metabolism—PIK3CG—malignant glioma	5.77e-06	5.81e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—SLC5A5—malignant glioma	5.73e-06	5.77e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	5.65e-06	5.69e-05	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism—PIK3CD—malignant glioma	5.63e-06	5.67e-05	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—CAT—malignant glioma	5.62e-06	5.66e-05	CbGpPWpGaD
Daunorubicin—ABCG2—Metabolism—PPARG—malignant glioma	5.62e-06	5.66e-05	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—NCOR1—malignant glioma	5.62e-06	5.66e-05	CbGpPWpGaD
Daunorubicin—XDH—Metabolism—PIK3CA—malignant glioma	5.58e-06	5.62e-05	CbGpPWpGaD
Daunorubicin—SLC22A2—Metabolism—PPARG—malignant glioma	5.57e-06	5.6e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	5.45e-06	5.49e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—IDH1—malignant glioma	5.35e-06	5.39e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—GSTT1—malignant glioma	5.32e-06	5.35e-05	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—NCOR1—malignant glioma	5.31e-06	5.35e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Transmembrane transport of small molecules—RAF1—malignant glioma	5.28e-06	5.31e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—PTEN—malignant glioma	5.24e-06	5.27e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—SPHK1—malignant glioma	5.18e-06	5.21e-05	CbGpPWpGaD
Daunorubicin—ABCG2—Metabolism—PIK3CD—malignant glioma	5.12e-06	5.16e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism—PIK3CB—malignant glioma	5.07e-06	5.11e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—CYP2C18—malignant glioma	5.07e-06	5.11e-05	CbGpPWpGaD
Daunorubicin—SLC22A2—Metabolism—PIK3CD—malignant glioma	5.07e-06	5.1e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism—PTGS2—malignant glioma	5.03e-06	5.06e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—PTGS1—malignant glioma	4.98e-06	5.02e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	4.96e-06	5e-05	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism—PIK3CB—malignant glioma	4.91e-06	4.94e-05	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism—PTGS2—malignant glioma	4.86e-06	4.9e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—STAT3—malignant glioma	4.68e-06	4.71e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—BCHE—malignant glioma	4.63e-06	4.66e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—GSTP1—malignant glioma	4.62e-06	4.65e-05	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—CAV1—malignant glioma	4.58e-06	4.61e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—SLC5A5—malignant glioma	4.58e-06	4.61e-05	CbGpPWpGaD
Daunorubicin—XDH—Metabolism—AKT1—malignant glioma	4.56e-06	4.59e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—CAT—malignant glioma	4.49e-06	4.52e-05	CbGpPWpGaD
Daunorubicin—ABCG2—Metabolism—PIK3CB—malignant glioma	4.46e-06	4.5e-05	CbGpPWpGaD
Daunorubicin—ABCG2—Metabolism—PTGS2—malignant glioma	4.42e-06	4.45e-05	CbGpPWpGaD
Daunorubicin—SLC22A2—Metabolism—PIK3CB—malignant glioma	4.42e-06	4.45e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism—PTEN—malignant glioma	4.38e-06	4.41e-05	CbGpPWpGaD
Daunorubicin—SLC22A2—Metabolism—PTGS2—malignant glioma	4.38e-06	4.41e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—MYC—malignant glioma	4.35e-06	4.38e-05	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—CAV1—malignant glioma	4.33e-06	4.36e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	4.33e-06	4.36e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	4.29e-06	4.32e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—EGFR—malignant glioma	4.26e-06	4.28e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—NCOR1—malignant glioma	4.24e-06	4.27e-05	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism—PTEN—malignant glioma	4.24e-06	4.27e-05	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—PIK3CG—malignant glioma	4.17e-06	4.2e-05	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	4.14e-06	4.17e-05	CbGpPWpGaD
Daunorubicin—ABCB11—Metabolism—PIK3CA—malignant glioma	4.12e-06	4.15e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—GSTT1—malignant glioma	4.1e-06	4.13e-05	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—PPARG—malignant glioma	4.03e-06	4.06e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—KRAS—malignant glioma	4.02e-06	4.05e-05	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—PIK3CG—malignant glioma	3.94e-06	3.97e-05	CbGpPWpGaD
Daunorubicin—ABCG2—Metabolism—PTEN—malignant glioma	3.86e-06	3.88e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—PTGS1—malignant glioma	3.85e-06	3.87e-05	CbGpPWpGaD
Daunorubicin—SLC22A2—Metabolism—PTEN—malignant glioma	3.82e-06	3.84e-05	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—PPARG—malignant glioma	3.81e-06	3.83e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	3.74e-06	3.76e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—PIK3CA—malignant glioma	3.69e-06	3.72e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—GSTP1—malignant glioma	3.69e-06	3.71e-05	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—PIK3CD—malignant glioma	3.67e-06	3.7e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—CAT—malignant glioma	3.59e-06	3.61e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—BCHE—malignant glioma	3.57e-06	3.6e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—SLC5A5—malignant glioma	3.53e-06	3.56e-05	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—PIK3CD—malignant glioma	3.47e-06	3.49e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—CAV1—malignant glioma	3.46e-06	3.48e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—NCOR1—malignant glioma	3.39e-06	3.41e-05	CbGpPWpGaD
Daunorubicin—ABCB11—Metabolism—AKT1—malignant glioma	3.36e-06	3.39e-05	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—PIK3CB—malignant glioma	3.2e-06	3.22e-05	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—PTGS2—malignant glioma	3.17e-06	3.19e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—PIK3CG—malignant glioma	3.15e-06	3.17e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism—PIK3CA—malignant glioma	3.09e-06	3.11e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—PPARG—malignant glioma	3.04e-06	3.06e-05	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—PIK3CB—malignant glioma	3.02e-06	3.04e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—AKT1—malignant glioma	3.02e-06	3.04e-05	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—PTGS2—malignant glioma	2.99e-06	3.02e-05	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism—PIK3CA—malignant glioma	2.99e-06	3.01e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—GSTP1—malignant glioma	2.84e-06	2.86e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—PIK3CD—malignant glioma	2.77e-06	2.79e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—CAT—malignant glioma	2.77e-06	2.79e-05	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—PTEN—malignant glioma	2.76e-06	2.78e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—CAV1—malignant glioma	2.76e-06	2.78e-05	CbGpPWpGaD
Daunorubicin—ABCG2—Metabolism—PIK3CA—malignant glioma	2.72e-06	2.74e-05	CbGpPWpGaD
Daunorubicin—SLC22A2—Metabolism—PIK3CA—malignant glioma	2.69e-06	2.71e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	2.64e-06	2.66e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—NCOR1—malignant glioma	2.61e-06	2.63e-05	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—PTEN—malignant glioma	2.61e-06	2.63e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism—AKT1—malignant glioma	2.53e-06	2.54e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—PIK3CG—malignant glioma	2.51e-06	2.53e-05	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism—AKT1—malignant glioma	2.44e-06	2.46e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—PPARG—malignant glioma	2.43e-06	2.44e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—PIK3CB—malignant glioma	2.41e-06	2.43e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—PTGS2—malignant glioma	2.39e-06	2.41e-05	CbGpPWpGaD
Daunorubicin—ABCG2—Metabolism—AKT1—malignant glioma	2.22e-06	2.24e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—PIK3CD—malignant glioma	2.21e-06	2.23e-05	CbGpPWpGaD
Daunorubicin—SLC22A2—Metabolism—AKT1—malignant glioma	2.2e-06	2.22e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—CAV1—malignant glioma	2.13e-06	2.15e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—PTEN—malignant glioma	2.09e-06	2.1e-05	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—PIK3CA—malignant glioma	1.95e-06	1.96e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—PIK3CG—malignant glioma	1.94e-06	1.95e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—PIK3CB—malignant glioma	1.93e-06	1.94e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—PTGS2—malignant glioma	1.91e-06	1.92e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—PPARG—malignant glioma	1.87e-06	1.89e-05	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—PIK3CA—malignant glioma	1.84e-06	1.85e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—PIK3CD—malignant glioma	1.71e-06	1.72e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—PTEN—malignant glioma	1.67e-06	1.68e-05	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—AKT1—malignant glioma	1.59e-06	1.6e-05	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—AKT1—malignant glioma	1.51e-06	1.52e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—PIK3CB—malignant glioma	1.49e-06	1.5e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—PTGS2—malignant glioma	1.47e-06	1.48e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—PIK3CA—malignant glioma	1.47e-06	1.48e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—PTEN—malignant glioma	1.29e-06	1.29e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—AKT1—malignant glioma	1.2e-06	1.21e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—PIK3CA—malignant glioma	1.17e-06	1.18e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—AKT1—malignant glioma	9.6e-07	9.66e-06	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—PIK3CA—malignant glioma	9.07e-07	9.13e-06	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—AKT1—malignant glioma	7.41e-07	7.46e-06	CbGpPWpGaD
